• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外交替链DNA三螺旋介导的HIV-1 U5长末端重复序列整合抑制作用

Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro.

作者信息

Bouziane M, Cherny D I, Mouscadet J F, Auclair C

机构信息

Laboratoire de Physicochimie et Pharmacologie des Macromolécules Biologiques CNRS URA 147, Institut Gustave Roussy, Rue Camille Desmoulins, 94805 Villejuif, France.

出版信息

J Biol Chem. 1996 Apr 26;271(17):10359-64. doi: 10.1074/jbc.271.17.10359.

DOI:10.1074/jbc.271.17.10359
PMID:8626607
Abstract

Integration of the human immunodeficiency virus (HIV) DNA into the host genome is an obligatory process in the replicative life cycle of the virus. This event is mediated in vitro by integrase, a viral protein which binds to specific sequences located on both extremities of the DNA long terminal repeats (LTRs). These sites are highly conserved in all HIV genomes and thus provide potential targets for the selective inhibition of integration. The integrase-binding site located on the HIV-1 U5 LTR end contains two adjacent purine tracts on opposite strands, 5' . . . GGAAAATCTCT-3'/3'-CCTTTTAGAGA . . . 5', in parallel orientations. A single strand oligonucleotide 5'-GGTTTTTGTGT-3' was designed to associate with these tracts via its ability to form a continuous alternate strand DNA triplex. Under neutral pH and physiological temperature, the oligonucleotide, tagged with an intercalator chromophore oxazolopyridocarbazole, formed a stable triplex with the target DNA. The occurrence of this unusual triplex was demonstrated by both DNase I footprinting and electron microscopy. The triplex inhibits the two steps of the integrase-mediated reactions, namely, the endonucleolytic cleavage of the dinucleotide 5'-GT-3' from the 3' end of the integration substrate and the integration of the substrate into the heterologous target DNA. The midpoints for both inhibition reactions were observed at oligonucleotide concentrations of 50-100 nM. We believe that these results open new possibilities for the specific targeting of viral DNA LTR ends with the view of inhibiting integration under physiological conditions.

摘要

人类免疫缺陷病毒(HIV)DNA整合到宿主基因组中是该病毒复制生命周期中的一个必需过程。这一事件在体外由整合酶介导,整合酶是一种病毒蛋白,它与位于DNA长末端重复序列(LTRs)两端的特定序列结合。这些位点在所有HIV基因组中高度保守,因此为选择性抑制整合提供了潜在靶点。位于HIV-1 U5 LTR末端的整合酶结合位点在相反链上包含两个两个相邻的嘌呤序列,5'...GGAAAATCTCT-3'/3'-CCTTTTAGAGA...5',呈平行方向。设计了一条单链寡核苷酸5'-GGTTTTTGTGT-3',通过其形成连续交替链DNA三链体的能力与这些序列结合。在中性pH和生理温度下,用嵌入剂发色团恶唑并吡啶咔唑标记的寡核苷酸与靶DNA形成了稳定的三链体。通过DNase I足迹法和电子显微镜都证明了这种不寻常三链体的存在。该三链体抑制整合酶介导反应的两个步骤,即从整合底物3'端进行二核苷酸5'-GT-3'的内切核酸酶切割以及底物整合到异源靶DNA中。在寡核苷酸浓度为50-100 nM时观察到两种抑制反应的中点。我们相信,这些结果为在生理条件下通过靶向病毒DNA LTR末端来抑制整合开辟了新的可能性。

相似文献

1
Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro.体外交替链DNA三螺旋介导的HIV-1 U5长末端重复序列整合抑制作用
J Biol Chem. 1996 Apr 26;271(17):10359-64. doi: 10.1074/jbc.271.17.10359.
2
Triplex-mediated inhibition of HIV DNA integration in vitro.三链体介导的体外HIV DNA整合抑制作用
J Biol Chem. 1994 Aug 26;269(34):21635-8.
3
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides.
Nucleosides Nucleotides. 1999 Jun-Jul;18(6-7):1717-8. doi: 10.1080/07328319908044831.
4
Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.抗HIV植物蛋白MAP30和GAP31对1型人类免疫缺陷病毒(HIV)整合酶的抑制作用。
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8818-22. doi: 10.1073/pnas.92.19.8818.
5
Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.底物和靶寡核苷酸序列均会影响由酿酒酵母中产生的1型人类免疫缺陷病毒整合酶蛋白介导的体外整合。
J Virol. 1992 Apr;66(4):2359-68. doi: 10.1128/JVI.66.4.2359-2368.1992.
6
Triple helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence.
Biochemistry. 1994 Apr 12;33(14):4187-96. doi: 10.1021/bi00180a011.
7
Activity of recombinant HIV-1 integrase on mini-HIV DNA.重组HIV-1整合酶对微型HIV DNA的活性
Nucleic Acids Res. 1999 May 15;27(10):2202-10. doi: 10.1093/nar/27.10.2202.
8
Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.人类免疫缺陷病毒脱氧核糖核酸整合的定量体外测定
Arch Biochem Biophys. 1993 Feb 1;300(2):756-60. doi: 10.1006/abbi.1993.1105.
9
[Interactions of HIV-1 DNA heterocyclic bases with viral DNA].[人类免疫缺陷病毒1型DNA杂环碱基与病毒DNA的相互作用]
Mol Biol (Mosk). 2004 Sep-Oct;38(5):848-57.
10
A molecular mechanics and dynamics study of alternate triple-helices involving the integrase-binding site of the HIV-1 virus and oligonucleotides having a 3'-3' internucleotide junction.
J Biomol Struct Dyn. 1996 Apr;13(5):835-53. doi: 10.1080/07391102.1996.10508896.

引用本文的文献

1
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription.将SRC嘧啶结合蛋白(SPy)鉴定为不均一核糖核蛋白K:对SRC1A转录调控的影响
Nucleic Acids Res. 2003 Mar 1;31(5):1502-13. doi: 10.1093/nar/gkg246.
2
Optimization of alternate-strand triple helix formation at the 5"-TpA-3" and 5"-ApT-3" junctions.在5'-TpA-3'和5'-ApT-3'连接处交替链三螺旋形成的优化。
Nucleic Acids Res. 1999 Aug 1;27(15):3029-34. doi: 10.1093/nar/27.15.3029.
3
Insertion sequences.插入序列
Microbiol Mol Biol Rev. 1998 Sep;62(3):725-74. doi: 10.1128/MMBR.62.3.725-774.1998.
4
Analysis of various sequence-specific triplexes by electron and atomic force microscopies.通过电子显微镜和原子力显微镜对各种序列特异性三链体进行分析。
Biophys J. 1998 Feb;74(2 Pt 1):1015-23. doi: 10.1016/S0006-3495(98)74026-3.
5
Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.肽核酸(PNA)以最低的PNA/RNA比例对HIV-1 gag逆转录进行高效体外抑制。
Nucleic Acids Res. 1997 Jun 1;25(11):2167-73. doi: 10.1093/nar/25.11.2167.